EMA releases results from February meeting, recommending two medicines
The EMA has recommended granting marketing authorisation to two medicines and extending the indications for three more following its latest meeting.
List view / Grid view
The EMA has recommended granting marketing authorisation to two medicines and extending the indications for three more following its latest meeting.
The FDA has given its approval to a new injection for cluster headaches which reduce frequency of attacks.